REQUEST A DEMO
Total
USD $0.00
Search more companies

Lecran Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Educational Services | General Medical and Surgical Hospitals
Full name: Lecran Sp. z o.o. Profile Updated: October 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Lecran Sp. z o.o is a company that focuses on treating chronic wounds, diabetes syndrome, and vascular diseases. They offer clinical trials, surgical treatment, and specialized podological treatment. The company also provides comprehensive wound care and foot care services. Lecran was founded to address the therapy of vascular complications of diabetes, venous convulsion, and other related conditions. The company is engaged in analyzing and improving their online services.

Headquarters
Ul. Trawowa 63A
Wroclaw; Dolnoslaskie; Postal Code: 54-614

Contact Details: Purchase the Lecran Sp. z o.o. report to view the information.

Website: http://lecran.pl

Basic Information
Registered Capital:
Purchase the Lecran Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Lecran Sp. z o.o. report to view the information.
Incorporation Date:
January 24, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Lecran Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
49.08%
Total operating revenue
49.18%
Operating profit (EBIT)
110.07%
EBITDA
126.49%
Net Profit (Loss) for the Period
106.34%
Total Assets
119.82%
Total Equity
197.1%
Operating Profit Margin (ROS)
2.35%
Net Profit Margin
1.96%
Return on Equity (ROE)
-29.18%
Debt/Equity
18.26%
Quick Ratio
0.24%
Cash Ratio
0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?